Physician profile
Michael Goins
NPI 1003920604
$1,855.63
in general payments reported to CMS, 2019-2025
10 companies · $607 in 2025
The $607 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $166 · 2023: $656 · 2024: $427 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $896.71 | 2022-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $448.26 | 2022-2025 | Descovy |
| Abbvie INC. | $177.55 | 2023-2025 | |
| Pfizer INC. | $78.63 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $73.50 | 2023-2025 | Pifeltro, Delstrigo |
| Bayer Healthcare Pharmaceuticals INC. | $64.36 | 2024 | |
| Exact Sciences Corporation | $62.62 | 2025 | The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $22.48 | 2024 | Aptima |
| Kowa Pharmaceuticals America, INC. | $18.18 | 2023 | Seglentis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.34 | 2023 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Goins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.